• Immune response to treatment with check point inhibitors
  • Immune profile as predictive markers of immunotherapy
  • Serum miRNA-signatures identifying lung cancer patients 
  • Molecular characterisation of lung carcinomas
  • Improving radiotherapy in lung cancer
  • Combinations of radiotherapy and immunotherapy to improve survival of lung cancer
    • Biomarkers of treatment effect
    • Radiotherapy to improve effect of immunotherapy
    • Immune response to radiotherapy
  • Protein analysis for early stage lung cancer
  • Biology of ALK-positive tumours 
Page visits: 96